Proscia: Choosing the Right Digital Pathology Platform: 7 Criteria for a Better Experience with Your AI Applications
recent articles
From the Proscia blog: Labs now expect their digital pathology platform to offer a broad range of AI applications from multiple vendors. But access alone isn’t enough. The platform also shapes how pathologists, scientists, and lab teams...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced U.S. commercial availability of the HyperVue Integrated System [1], a new single room-based configuration of its...
From Indica Labs: As a leading provider of laboratory services in genomics, multiomics and healthcare diagnostics, Source BioScience is leveraging large-scale digital pathology to support over 90 partner NHS trusts. Interoperability and...
From Diagnexia on LinkedIn: Delighted to share that Diagnexia has been shortlisted for Health Tech Product of the Year at the LaingBuisson Awards 2026. A huge congratulations to our incredible team and partners for driving innovation and...
From Indica Labs: For researchers using in situ hybridization, optimization of both probing conditions and the analysis approach is necessary for the clearest results, yet the process of identifying the best values can be time consuming....
Philadelphia - October 27, 2026 - Proscia has entered into a collaborative agreement with Columbia University to identify biomarkers for neurodegenerative diseases, such as Alzheimer’s and other dementias. The collaboration pairs Columbia’s...
